This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Tokyo. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Katsunori Semi in Cancer Therapeutics
Introduction
Katsunori Semi is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of cancer research through his innovative methods for screening therapeutic agents. His work aims to enhance the development of targeted cancer treatments.
Latest Patents
Katsunori Semi holds a patent for a "Method for screening for cancer therapeutic agent." This invention provides a novel approach to identifying therapeutic drugs for cancer by targeting specific proteins among a range of candidate proteins. The method involves expressing an exogenous cell regulatory factor in target cancer cells, confirming changes in the cancer cells, and selecting test substances as potential therapeutic drugs based on observed effects.
Career Highlights
Katsunori Semi is affiliated with the University of Tokyo, where he continues to advance his research in cancer therapeutics. His work is characterized by a focus on molecular-targeted drugs, which are crucial for developing effective cancer treatments.
Collaborations
Katsunori Semi collaborates with esteemed colleagues, including Yasuhiro Yamada and Knut Woltjen. These partnerships enhance the research efforts and contribute to the advancement of cancer therapeutic methods.
Conclusion
Katsunori Semi's innovative approach to cancer treatment through his patented method exemplifies the potential for advancements in medical research. His contributions are vital for the ongoing fight against cancer and highlight the importance of targeted therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
